Hepatic failure caused by plasma cell infiltration in multiple myeloma

World Journal of Gastroenterology

Volumn 15, Issue 16, 2009, Pages 2038-2040

  Rahhal, Fadi E ^a   Schade, Robert R ^a   Nayak, Asha ^a   Coleman, Teresa A ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Cell infiltration; Hepatic failure; Multiple myeloma

Indexed keywords

BILIRUBIN; BORTEZOMIB; DEXAMETHASONE; IMMUNOGLOBULIN KAPPA CHAIN; THALIDOMIDE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD CLOTTING DISORDER; BONE MARROW BIOPSY; BRAIN DISEASE; CACHEXIA; CASE REPORT; CELL INFILTRATION; CHOLESTASIS; CHROMOSOME 13; CHROMOSOME 16; CHROMOSOME 17; CHROMOSOME 21; CHROMOSOME 4; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FATTY LIVER; HEPATOMEGALY; HUMAN; HUMAN TISSUE; HYPERBILIRUBINEMIA; JAUNDICE; LIVER BIOPSY; LIVER FAILURE; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; PHYSICAL EXAMINATION; SIDE EFFECT; TREATMENT DURATION;

FATAL OUTCOME; HUMANS; LIVER; LIVER FAILURE; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PLASMA CELLS;

EID: 67651159088     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.2038     Document Type: Article

References (23)

1. Kapadia SB. Multiple myeloma: a clinicopathologic study of 62 consecutively autopsied cases. Medicine (Baltimore) 1980; 59: 380-392
2. Kyle RA. Multiple myeloma: review of 869 cases. Mayo Clin Proc 1975; 50: 29-40
3. Perez-Soler R, Esteban R, Allende E, Tornos Salomo C, Julia A, Guardia J. Liver involvement in multiple myeloma. Am J Hematol 1985; 20: 25-29
4. Thomas FB, Clausen KP, Greenberger NJ. Liver disease in multiple myeloma. Arch Intern Med 1973; 132: 195-202
5. Walz-Mattmüller R, Horny HP, Ruck P, Kaiserling E. Incidence and pattern of liver involvement in haematological malignancies. Pathol Res Pract 1998; 194: 781-789
6. Barth C, Bosse A, Andus T. Severe acute cholestatic hepatitis by infiltration of monoclonal plasma cells in multiple myeloma. Z Gastroenterol 2005; 43: 1129-1132
7. Yaǧcí M, Sucak GT, Akyol G, Haznedar R. Hepatic failure due to CD3+ plasma cell infiltration of the liver in multiple myeloma. Acta Haematol 2002; 107: 38-42
8. Thiruvengadam R, Penetrante RB, Goolsby HJ, Silk YN, Bernstein ZP. Multiple myeloma presenting as space-occupying lesions of the liver. Cancer 1990; 65: 2784-2786
9. Fischer A, Suhrland MJ, Vogl SE. Myeloma of the head of the pancreas. A case report. Cancer 1991; 67: 681-683
10. Lake G, Schade RR, Van Thiel DH. Extrahepatic biliary tract obstruction due to plasmacytoma. J Clin Gastroenterol 1983; 5: 273-276
11. Michopoulos S, Petraki K, Petraki C, Dimopoulos MA. Light chain deposition disease of the liver without renal involvement in a patient with multiple myeloma related to liver failure and rapid fatal outcome. Dig Dis Sci 2002; 47: 730-734
12. Ales NC, Daniels JT, Frizell ER, Koff JM, Kaplan KJ, Wortmann GW. Multiple myeloma-associated amyloidosis manifesting as fulminant hepatic failure. South Med J 2001; 94: 1036-1038
13. Yamamoto T, Maeda N, Kawasaki H. Hepatic failure in a case of multiple myeloma-associated amyloidosis (kappa-AL) J Gastroenterol 1995; 30: 393-397
14. Berríos M, Armas-Merino R, Franco C, Parrochia E, Wolff C. [Acute Liver Failure in patient with liver amyloidosis associated to multiple myeloma] Rev Med Chil 2003; 131: 1301-1304
15. Macías Robles MD, Navia-Osorio García-Braga JM, Menéndez Caro JL, Velasco Alonso J, López Lagunas I. [Jaundice secondary to intrahepatic deposit of light chains as a presenting form of multiple myeloma] An Med Interna 1994; 11: 74-76
16. Licht A, Maurer R, Oelz O. Myeloma and severe cholestasis. Schweiz Med Wochenschr 1999; 129: 1201-1204
17. Terada T, Hirata K, Hisada Y, Hoshii Y, Nakanuma Y. Obstructive jaundice caused by the deposition of amyloid-like substances in the extrahepatic and large intrahepatic bile ducts in a patient with multiple myeloma. Histopathology 1994; 24: 485-487
18. Calomeni JA, Smith JR. Obstructive jaundice from hepatic amyloidosis in a patient with multiple myeloma. Am J Hematol 1985; 19: 277-279
19. Solves P, de la Rubia J, Jarque I, Cervera J, Sanz GF, Vera-Sempere FJ, Sanz MA. Liver disease as primary manifestation of multiple myeloma in a young man. Leuk Res 1999; 23: 403-405
20. Pastor E, Perella M, Gómez A, Grau E, Pérez A, Escandón J. Multiple myeloma of the liver presenting as nonobstructive jaundice. Am J Hematol 1996; 53: 205-206
21. Talamo G, Cavallo F, Zangari M, Barlogie B, Lee CK, Pineda-Roman M, Kiwan E, Krishna S, Tricot G. Clinical and biological features of multiple myeloma involving the gastrointestinal system. Haematologica 2006; 91: 964-967
22. Trojan A, Chasse E, Gay B, Pichert G, Taverna C. Severe hepatic toxicity due to thalidomide in relapsed multiple myeloma. Ann Oncol 2003; 14: 501-502
23. Rosiñol L, Montoto S, Cibeira MT, Bladé J. Bortezomib-induced severe hepatitis in multiple myeloma: a case report. Arch Intern Med 2005; 165: 464-465